Rui Wu

Company: Graviton BioScience

Job title: Chief Officer ,Senior Vice President & Head of Research & Preclinical ,Chemistry, Manufacturing & Controls

Seminars:

Understanding & Targeting Renal Fibrosis to Advance Antifibrotic Innovation 9:30 am

Explore the key signalling pathways and cellular players including myofibroblasts, epithelial cells, macrophages driving CKD progression and fibrogenesis Explore omics-driven insights into spatial and cellular heterogeneity within nephron structures to inform more precise therapeutic approaches Examine the promise of ROCK2 inhibition, including preclinical and early clinical findings from GRV-101, and how biomarker-driven strategies are guiding…Read more

day: Conference Day One